Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTRECTINIB vs EPIRUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENTRECTINIB vs EPIRUBICIN: Safety Overview

Metric ENTRECTINIB EPIRUBICIN
Total FAERS Reports 1,491 16,274
Deaths Reported 246 2,212
Death Rate 16.5% 13.6%
Hospitalizations 316 5,603
Average Patient Age 59.8 yrs 52.8 yrs
% Female Patients 58.1% 86.1%
FDA Approval Date Aug 15, 2019 Apr 15, 2011
Manufacturer Genentech, Inc. Pharmacia & Upjohn Company LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription